Drug Shortage Report for ZEVALIN
| Report ID | 109828 |
| Drug Identification Number | 02328674 |
| Brand name | ZEVALIN |
| Common or Proper name | Kit for the preparation of 90Y-ibritumomab tiuxetan |
| Company Name | AURO PHARMA INC |
| Market Status | APPROVED |
| Active Ingredient(s) | IBRITUMOMAB TIUXETAN |
| Strength(s) | 3.2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | Ibritumomab tiuxetan drug product: 3 mL glass vial; Formulation buffer: 10 mL glass vial; 50 mM sodium acetate: 3 mL glass vial; Empty reaction vial: 10 mL glass vial. |
| ATC code | V10XX |
| ATC description | |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2020-05-29 |
| Estimated end date | Unknown |
| Actual end date | 2020-06-30 |
| Shortage status | Resolved |
| Updated date | 2020-07-01 |
| Company comments | N/A |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v14 | 2020-07-01 | English | Compare |
| v13 | 2020-06-30 | French | Compare |
| v12 | 2020-06-30 | English | Compare |
| v11 | 2020-05-30 | English | Compare |
| v10 | 2020-05-29 | English | Compare |
| v9 | 2020-05-29 | French | Compare |
| v8 | 2020-05-29 | English | Compare |
| v7 | 2020-05-29 | English | Compare |
| v6 | 2020-05-29 | English | Compare |
| v5 | 2020-05-29 | French | Compare |
| v4 | 2020-05-29 | English | Compare |
| v3 | 2020-03-30 | French | Compare |
| v2 | 2020-03-30 | English | Compare |
| v1 | 2020-03-30 | English | Compare |
Showing 1 to 14 of 14